Richard Domanik, PhD, has been named the new president of CytoCore (Chicago). Domanik co-founded two developmental medical device technology companies and is familiar with the foundation work and science for CytoCore's InPath system. CytoCore is an biopharmaceutical research and medical device company developing products for the early detection and treatment of reproductive-tract cancers.

George Sun has been named VP of regional sales of Healthvision (Irving, Texas). Sun previously worked as VP of national accounts for Spacenet. Healthvision is an information technology solutions provider.

Robert Tuttle has been named VP of research and development of HepaLife Technologies (Boston). Tuttle will assist the company with development of its new bioartificial heart. Previously, Tuttle was on HepaLife's scientific advisory board. HepaLife is focused on the identification and development of cell-based technologies and products.

No Comments